Product Theaters
Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis
FRIDAY, OCTOBER 17, 2025
12:00 - 12:55 PM
Randolph Room
Speaker: Diego DaSilva, MD
Supported by UCB
An Option to Choose Tremfya First -- A deep dive into the TREMFYA® clinical data in moderate to severe plaque PsO and active PsA (including new data on structural inhibition)
FRIDAY, OCTOBER 17, 2025
5:30 - 6:30 PM
Riverview Room
Speaker: Fabrizio Galimberti, MD
Supported by J&J
Don’t Wait: A Patient Case-Based Approach to Treating with an Oral Therapy Approved for Plaque Psoriasis or Psoriatic Arthritis
SATURDAY, OCTOBER 18
7:00 - 8:00 AM
Randolph Room
Speaker: Saurabh Singh, MD
Supported by Amgen
Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
SATURDAY, OCTOBER 18
Noon - 1:00 PM
Randolph Room
Speaker: Ben Lockshin, MD
Supported by Sanofi/Regeneron
The IL-31 neuroimmune Pathway: A Key to Atopic Dermatitis and Prurigo Nodularis
SUNDAY, OCTOBER 19
7:00 - 8:00 AM
Randolph Room
Speaker: Diego Dasilva, MD
Supported by Galderma